1
Mark A Gallop, Ge Peng, Thomas F Woiwode, Kenneth C Cundy: Gemcitabine prodrugs, pharmaceutical compositions and uses thereof. XenoPort, Dorsey & Whitney, September 4, 2007: US07265096 (36 worldwide citation)

The present invention provides gemcitabine prodrugs, methods of making gemcitabine prodrugs, pharmaceutical compositions of gemcitabine prodrugs and methods of using gemcitabine prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as cancer or viral infecti ...


2
Mark A Gallop, Ge Peng, Thomas F Woiwode, Kenneth C Cundy: Gemcitabine prodrugs, pharmaceutical compositions and uses thereof. XenoPort, Dorsey & Whitney, October 27, 2009: US07608602 (4 worldwide citation)

The present invention provides gemcitabine prodrugs, methods of making gemcitabine prodrugs, pharmaceutical compositions of gemcitabine prodrugs and methods of using gemcitabine prodrugs and pharmaceutical compositions of using gemcitabine prodrugs to treat or prevent diseases or disorders such as c ...


3
Mark A Gallop, Ge Peng, Thomas F Woiwode, Kenneth C Cundy: Gemcitabine prodrugs, pharmaceutical compositions and uses thereof. XenoPort, Dorsey & Whitney, September 28, 2010: US07803785 (3 worldwide citation)

The present invention provides gemcitabine prodrugs, methods of making gemcitabine prodrugs, pharmaceutical compositions of gemcitabine prodrugs and methods of using gemcitabine prodrugs and pharmaceutical compositions of using gemcitabine prodrugs to treat or prevent diseases or disorders such as c ...


4
Ronald W Barrett, William J Dower, Mark Gallop, Thomas F Woiwode, Steven E Cwirla: Compounds displayed on replicable genetic packages and methods of using same. Xenoport, Townsend and Townsend and Crew, May 2, 2006: US07037706 (3 worldwide citation)

Replicable genetic packages and collections thereof that display various compounds are provided. In some instances, the replicable genetic packages include nucleic acid tags that serve to record a characteristic of the compound or compounds that are attached to the replicable genetic package. The in ...


5
Ronald W Barrett, William J Dower, Mark Gallop, Thomas F Woiwode, Steven E Cwirla: Compounds displayed on icosahedral phage and methods of using same. Xenoport, Townsend and Townsend and Crew, June 12, 2007: US07229757 (2 worldwide citation)

Icosahedral phage and collections thereof that display various compounds are provided. In some instances, the icosahedral phage include nucleic acid tags that serve to record a characteristic of the compound or compounds that are attached to the phage. A number of different methods for using the ico ...


6
Ronald W Barrett, William J Dower, Mark Gallop, Thomas F Woiwode, Steven E Cwirla: Compounds displayed on replicable genetic packages and methods of using same. XenoPort, Townsend and Townsend and Crew, April 14, 2009: US07517643

Replicable genetic packages and collections thereof that display various compounds are provided. In some instances, the replicable genetic packages include nucleic acid tags that serve to record a characteristic of the compound or compounds that are attached to the replicable genetic package. The in ...


7
Mark A Gallop, Ge Peng, Thomas F Woiwode, Kenneth C Cundy: Gemcitabine prodrugs, pharmaceutical compositions and uses thereof. Cooley Godward, July 22, 2004: US20040142857-A1

The present invention provides gemcitabine prodrugs, methods of making gemcitabine prodrugs, pharmaceutical compositions of gemcitabine prodrugs and methods of using gemcitabine prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as cancer or viral infecti ...


8
Ronald W Barrett, William J Dower, Mark Gallop, Thomas F Woiwode, Steven E Cwirla: Compounds displayed on icosahedral phage and methods of using same. XenoPort, Townsend And Townsend And Crew, April 12, 2007: US20070082330-A1

Icosahedral phage and collections thereof that display various compounds are provided. In some instances, the icosahedral phage include nucleic acid tags that serve to record a characteristic of the compound or compounds that are attached to the phage. A number of different methods for using the ico ...


9
Mark A Gallop, Ge Peng, Thomas F Woiwode, Kenneth C Cundy: Gemcitabine Prodrugs, Pharmaceutical Compositions and Uses Thereof. XenoPort, Dorsey & Whitney, January 24, 2008: US20080021208-A1

The present invention provides gemcitabine prodrugs, methods of making gemcitabine prodrugs, pharmaceutical compositions of gemcitabine prodrugs and methods of using gemcitabine prodrugs and pharmaceutical compositions of using gemcitabine prodrugs to treat or prevent diseases or disorders such as c ...


10
Ronald W Barrett, William J Dower, Mark Gallop, Thomas F Woiwode, Steven E Cwirla: Compounds displayed on replicable genetic packages and methods of using same. Xenoport, Townsend And Townsend And Crew, November 17, 2005: US20050255462-A1

Replicable genetic packages and collections thereof that display various compounds are provided. In some instances, the replicable genetic packages include nucleic acid tags that serve to record a characteristic of the compound or compounds that are attached to the replicable genetic package. The in ...